drugset / Trial / NCT00621751

Carbamazepine for the Treatment of Chronic Post-Traumatic Brain Injury Irritability and Aggression

NCT00621751 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if carbamazepine reduces irritability and aggression among individuals with traumatic brain injury

Timeline

Start
2008-02
Primary completion
2013-09
Completion
2013-10

Outcome

Missed primary endpoint

registry analysis (other test); Carbamazepine vs Placebo; p = 0.60 NCT00621751 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbamazepine Small molecule 800 mg —